Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a summary of recent recommendations and […]
Sera Prognostics (NASDAQ:SERA – Get Rating) and Celcuity (NASDAQ:CELC – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Insider & Institutional Ownership 63.2% of Sera Prognostics shares are […]
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Sera Prognostics to related companies based on the strength of its analyst recommendations, earnings, profitability, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares […]
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare Sera Prognostics to related businesses based on the strength of its earnings, risk, institutional ownership, dividends, profitability, analyst recommendations and valuation. Profitability This table compares […]
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare Sera Prognostics to similar companies based on the strength of its dividends, institutional ownership, risk, profitability, analyst recommendations, valuation and earnings. Earnings & Valuation This table compares […]